IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,415 | -22.9% | 63,388 | +19.4% | 0.00% | -33.3% |
| Q2 2023 | $373,866 | +78.4% | 53,106 | +54.8% | 0.00% | +50.0% |
| Q1 2023 | $209,579 | -1.8% | 34,301 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $213,394 | -30.5% | 33,395 | +4.3% | 0.00% | -33.3% |
| Q3 2022 | $307,000 | -13.0% | 32,033 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -37.5% | 31,945 | -5.9% | 0.00% | -40.0% |
| Q1 2022 | $565,000 | -11.3% | 33,930 | +1.6% | 0.01% | 0.0% |
| Q4 2021 | $637,000 | -22.4% | 33,381 | +0.2% | 0.01% | -28.6% |
| Q3 2021 | $821,000 | -1.3% | 33,308 | +4.2% | 0.01% | 0.0% |
| Q2 2021 | $832,000 | -17.9% | 31,962 | -0.2% | 0.01% | -22.2% |
| Q1 2021 | $1,014,000 | -31.4% | 32,026 | +0.5% | 0.01% | -30.8% |
| Q4 2020 | $1,478,000 | +38.3% | 31,852 | -1.9% | 0.01% | +18.2% |
| Q3 2020 | $1,069,000 | +60.8% | 32,459 | +33.9% | 0.01% | +22.2% |
| Q2 2020 | $665,000 | -11.8% | 24,241 | -3.7% | 0.01% | -30.8% |
| Q1 2020 | $754,000 | – | 25,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |